Remepy Company Profile, Contacts & Intelligence

Remepy Overview

Remepy is Pioneering Hybrid Drugs™. Many medical conditions are better treated by combining pharmaceutical and non-pharmaceutical treatments. Hybrid drugs are a new type of drug asset, that combines traditional drugs with proprietary treatment protocols delivered measured and adapted using our AI capabilities. Remepy’s Digital Molecules™ are designed to be the software apps within Hybrid Drugs™. They are based on digital interventions and treatment protocols that are tailored to each medical condition and its corresponding drug and are constantly measured and tracked and personalized using advanced AI capabilities. The Digital Molecules™ enhance brain functions that balance the patient's neuro-endocrine and neuro-immunological systems and boost brain neuroplasticity, in order to optimize drug performance. We also address physical, motor, psychological, and behavioral symptoms Remepy partners with pharma companies to bring Hybrid Drugs™ to market that will combine Remepy’s Digital Molecule™ and traditional drug components.

Headquarters

New York, Ny, United States

Website

www.remepy.com

Industry

Biotechnology Research

Founded

2022

Stock Symbol

CENTE

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Remepy Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Remepy People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Remepy Workforce Composition

Seniority breakdown across 3 visible profiles.

Remepy Technology & Talent

Technology-related job titles represented in the visible people data.

Compare Similar Companies to Remepy

Explore companies in related markets and compare their industry and employee estimates.